Please assess the completion status of the following clinical trial:

Trial Title: Flow Augmentation Study in Postthrombotic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Post-thrombotic obstruction that requires percutaneous intervention through stenting, minimally 18 years of age~Exclusion Criteria:~* Peripheral arterial disease, comorbidities leading to impaired muscle function of either lower limb, co-morbidities affecting the circulatory system, history of deep venous surgery in either lower limb or groin, allergies to the plasters, pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Geko Device (Type: ACTIVE_COMPARATOR): Neuromuscular Stimulator
- IPCS (Type: ACTIVE_COMPARATOR): Intermittent Pneumotic Compression Stocking

Based on this trial design, predict the completion outcome and termination type (if applicable).